Q4 2022 Holdings
Filed 2023-01-31 | 391 holdings | $248.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-05-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Erasca Inc(ERAS)A | Common Stock | 29479A108 | $5.4K | 1,243 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD)A | Common Stock | 23257D103 | $5.4K | 860 | 0.0% |
| Ardelyx Inc(ARDX)A | Common Stock | 039697107 | $5.4K | 1,904 | 0.0% |
| Protagonist Therapeutics Inc(PTGX)A | Common Stock | 74366E102 | $5.5K | 500 | 0.0% |
| Cincor Pharma IncA | Common Stock | 17240Y109 | $5.5K | 444 | 0.0% |
| Siga Technologies Inc(SIGA)A | Common Stock | 826917106 | $5.5K | 742 | 0.0% |
| Hutchmed China(HCM)A | ADR | 44842L103 | $5.5K | 375 | 0.0% |
| Maxcyte Inc(MXCT)A | Common Stock | 57777K106 | $5.7K | 1,037 | 0.0% |
| Hillevax IncA | Common Stock | 43157M102 | $5.7K | 339 | 0.0% |
| Edgewise Therapeutics Inc(EWTX)A | Common Stock | 28036F105 | $5.7K | 642 | 0.0% |
| Bluebird BIO IncA | Common Stock | 09609G100 | $5.8K | 842 | 0.0% |
| Design Therapeutics Inc(DSGN)A | Common Stock | 25056L103 | $5.8K | 568 | 0.0% |
| Cara Therapeutics Inc(CARAEUR)A | Common Stock | 140755109 | $5.9K | 546 | 0.0% |
| Mersana Therapeutics IncA | Common Stock | 59045L106 | $5.9K | 1,014 | 0.0% |
| 89Bio Inc(ETNBGBP)A | Common Stock | 282559103 | $6.0K | 473 | 0.0% |
| Galapagos NV(GLPG)A | ADR | 36315X101 | $6.0K | 136 | 0.0% |
| Procter & Gamble Co(PG)A | Common Stock | 742718109 | $6.1K | 40 | 0.0% |
| Dyne Therapeutics Inc(DYN)A | Common Stock | 26818M108 | $6.1K | 530 | 0.0% |
| Wave Life Sciences LTD(WVE)A | Common Stock | Y95308105 | $6.2K | 883 | 0.0% |
| Editas Medicine Inc(EDIT)A | Common Stock | 28106W103 | $6.2K | 698 | 0.0% |
| Aurinia Pharmaceuticals Inc(AUPH)A | Common Stock | 05156V102 | $6.2K | 1,444 | 0.0% |
| Coherus Biosciences Inc(CHRS)A | Common Stock | 19249H103 | $6.3K | 790 | 0.0% |
| Repare Therapeutics Inc(RPTX)A | Common Stock | 760273102 | $6.3K | 426 | 0.0% |
| 23Andme Holding CoA | Common Stock | 90138Q108 | $6.3K | 2,913 | 0.0% |
| Castle Biosciences Inc(CSTL)A | Common Stock | 14843C105 | $6.3K | 268 | 0.0% |
| Exact Sciences Corp(EXAS)A | Common Stock | 30063P105 | $6.3K | 128 | 0.0% |
| Tango Therapeutics Inc(TNGX)A | Common Stock | 87583X109 | $6.5K | 896 | 0.0% |
| Schrodinger Inc(SDGR)A | Common Stock | 80810D103 | $6.5K | 350 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR)A | Common Stock | 75382E109 | $6.8K | 345 | 0.0% |
| Dada Nexus LTD(D0A)A | ADR | 23344D108 | $7.0K | 1,000 | 0.0% |
| Iteos Therapeutics Inc(5E7)A | Common Stock | 46565G104 | $7.1K | 361 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR)A | Common Stock | 81750R102 | $7.1K | 1,265 | 0.0% |
| ANI Pharmaceuticals Inc(ANIP)A | Common Stock | 00182C103 | $7.2K | 178 | 0.0% |
| Allakos Inc(ALLKGUSD)A | Common Stock | 01671P100 | $7.3K | 865 | 0.0% |
| Merus NVA | Common Stock | N5749R100 | $7.3K | 471 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM)A | Common Stock | 604749101 | $7.3K | 374 | 0.0% |
| 4D Molecular Therapeutics in(FDMT)A | Common Stock | 35104E100 | $7.3K | 329 | 0.0% |
| Anavex Life Sciences Corp(AVXL)A | Common Stock | 032797300 | $7.3K | 792 | 0.0% |
| Sana Biotechnology Inc(SANA)A | Common Stock | 799566104 | $7.7K | 1,938 | 0.0% |
| Bicycle Therapeutics PLC(BCYC)A | ADR | 088786108 | $7.7K | 259 | 0.0% |
| Theravance Biopharma Inc(TBPH)A | Common Stock | G8807B106 | $7.7K | 684 | 0.0% |
| Alector Inc(ALEC)A | Common Stock | 014442107 | $7.8K | 840 | 0.0% |
| Adma Biologics Inc(ADMA)A | Common Stock | 000899104 | $7.8K | 1,999 | 0.0% |
| Collegium Pharmaceutical Inc(COLL)A | Common Stock | 19459J104 | $7.9K | 341 | 0.0% |
| ARS Pharmaceuticals Inc(SPRY)A | Common Stock | 82835W108 | $8.1K | 953 | 0.0% |
| Cogent Biosciences Inc(COGT)A | Common Stock | 19240Q201 | $8.2K | 710 | 0.0% |
| Altimmune Inc(ALT)A | Common Stock | 02155H200 | $8.2K | 499 | 0.0% |
| 10X Genomics Inc(TXG)A | Common Stock | 88025U109 | $8.3K | 228 | 0.0% |
| Kura Oncology Inc(KURA)A | Common Stock | 50127T109 | $8.6K | 693 | 0.0% |
| Summit Therapeutics Inc(SMMT)A | Common Stock | 86627T108 | $8.7K | 2,045 | 0.0% |